Related Experiment Video
Updated: Jun 15, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function
Aymone Gurtner1, Giuseppe Starace, Giuseppe Norelli
1Molecular Oncogenesis Laboratory, Department of Experimental Oncology, Regina Elena Cancer Institute, Via delle Messi D'Oro 156, 00158 Rome, Italy.
Abstract:
Mitogen-activated protein kinase kinase 3 (MAP2K3) is a member of the dual specificity kinase group. Growing evidence links MAP2K3 to invasion and tumor progression. Here, we identify MAP2K3 as a transcriptional target of endogenous gain-of-function p53 mutants R273H, R175H, and R280K. We show that MAP2K3 modulation occurred at the mRNA and protein levels and that endogenous mutant p53 proteins are capable of binding to and activate the MAP2K3 promoter. In addition, we found that the studied p53 mutants regulate MAP2K3 gene expression through the involvement of the transcriptional cofactors NF-Y and NF-kappaB. Finally, functional studies showed that endogenous MAP2K3 knockdown inhibits proliferation and survival of human tumor cells, whereas the ectopic expression of MAP2K3 can rescue the proliferative defect induced by mutant p53 knockdown. Taken together, our findings define a novel player through which mutant p53 exerts its gain-of-function activity in cancer cells.
Insights
Gain-of-function p53 mutants regulate MAP2K3 expression, promoting cancer cell proliferation and survival. Targeting MAP2K3 offers a novel strategy against mutant p53-driven cancers.
Area of Science:
- Molecular Biology
- Cancer Research
- Signal Transduction
Background:
- Mitogen-activated protein kinase kinase 3 (MAP2K3) is implicated in cancer invasion and progression.
- Gain-of-function (GOF) p53 mutants are frequently observed in human cancers and contribute to tumor development.
- Understanding the regulatory mechanisms of MAP2K3 in cancer is crucial for therapeutic development.
Purpose of the Study:
- To investigate MAP2K3 as a transcriptional target of endogenous GOF p53 mutants.
- To elucidate the molecular mechanisms by which GOF p53 mutants regulate MAP2K3.
- To determine the functional role of MAP2K3 in cancer cell proliferation and survival under GOF p53 conditions.
Main Methods:
- Identification of MAP2K3 as a transcriptional target using p53 mutant expression models.
- Analysis of MAP2K3 mRNA and protein levels.
- Chromatin immunoprecipitation assays to assess p53 binding to the MAP2K3 promoter.
- Reporter assays to evaluate promoter activity.
- Knockdown and ectopic expression studies of MAP2K3 in human tumor cells.
Main Results:
- Endogenous GOF p53 mutants (R273H, R175H, R280K) directly activate the MAP2K3 promoter.
- MAP2K3 expression is modulated at both mRNA and protein levels by these p53 mutants.
- Transcriptional cofactors NF-Y and NF-kappaB are involved in p53-mediated MAP2K3 regulation.
- MAP2K3 knockdown inhibits proliferation and survival of human tumor cells.
- Ectopic MAP2K3 expression rescues the proliferative defect caused by mutant p53 knockdown.
Conclusions:
- MAP2K3 is a novel transcriptional target of GOF p53 mutants.
- Mutant p53 promotes cancer cell proliferation and survival through the upregulation of MAP2K3.
- MAP2K3 represents a potential therapeutic target for cancers harboring GOF p53 mutations.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
